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The development of gene therapies into effective tools for molecular medicine can be contributed to the 
successful outcomes of clinical trials followed by therapeutic product approval. Despite this, there are still many 
challenges to product development, including the scalability of the process and translating laboratory research 
into viable clinical applications. Cell expansion is currently labour and time intensive, and the processes lack the 
reproducibility and standardisation for regulatory and commercial compliant production. 
 
This research aims to improve current gene therapy manufacturing processes by developing a standardised 
process for manufacturing to a clinical grade standard. One avenue to achieve this is by increasing the overall 
cell yield and lentivirus titre. Initial experiments showed that implementing standardisation techniques and set 
seeding densities produced more favourable results than generic 1 in 3 splits. Overall applying the set seeding 
densities led to stable growth and routine passages, thereby reducing the reliance on visual confluency 
estimations. This resulted in a more predictable and reliable process that also had set culture periods, 
consistent harvest densities and fold expansions that were maintained over long culture periods, ranging 
between 3x105 and 4x105 cells/cm2 and 15-20 fold expansions per passage. Thereby creating a more suitable 
clinical grade manufacturing process which could be applied to both gene therapy and CAR-T cell therapy 
vector production. 
 
Future work aims investigate what factors influence transfection, discern what differences in approach are 
required for the different types of gene therapy and if a standard methodology can be developed for each 
approach. 
 
 
 
 
 
